Olga Bloch

489 total citations
24 papers, 331 citations indexed

About

Olga Bloch is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Olga Bloch has authored 24 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 6 papers in Genetics. Recurrent topics in Olga Bloch's work include Diabetes Treatment and Management (7 papers), Diabetes and associated disorders (5 papers) and Pancreatic function and diabetes (4 papers). Olga Bloch is often cited by papers focused on Diabetes Treatment and Management (7 papers), Diabetes and associated disorders (5 papers) and Pancreatic function and diabetes (4 papers). Olga Bloch collaborates with scholars based in Israel and Canada. Olga Bloch's co-authors include Micha J. Rapoport, Pnina Vardi, Konstantin Bloch, Yair Molad, Yona Eli, Efrat Broide, Amir Sharabi, Heidy Zinger, Edna Mozes and Dorit Aharoni and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Olga Bloch

24 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Bloch Israel 13 107 93 86 82 52 24 331
Xiao Xiang Yan China 12 76 0.7× 95 1.0× 65 0.8× 129 1.6× 15 0.3× 16 463
Sara Bruzzaniti Italy 12 163 1.5× 44 0.5× 67 0.8× 161 2.0× 25 0.5× 24 487
Hedieh Moradi Tabriz Iran 11 23 0.2× 69 0.7× 98 1.1× 72 0.9× 15 0.3× 42 345
Masanori Nishino Japan 9 132 1.2× 143 1.5× 142 1.7× 71 0.9× 19 0.4× 11 417
Beina Teng Germany 15 57 0.5× 28 0.3× 60 0.7× 232 2.8× 19 0.4× 21 579
Zhiyuan Zhao China 9 49 0.5× 52 0.6× 64 0.7× 151 1.8× 7 0.1× 16 382
Anna Balcerzyk Poland 12 31 0.3× 43 0.5× 125 1.5× 88 1.1× 21 0.4× 44 392
Yujie Zhou China 12 51 0.5× 70 0.8× 46 0.5× 121 1.5× 35 0.7× 37 373
Jürgen Herwig Germany 9 193 1.8× 192 2.1× 100 1.2× 157 1.9× 115 2.2× 12 705
E Roper United States 9 357 3.3× 118 1.3× 40 0.5× 109 1.3× 127 2.4× 10 612

Countries citing papers authored by Olga Bloch

Since Specialization
Citations

This map shows the geographic impact of Olga Bloch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Bloch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Bloch more than expected).

Fields of papers citing papers by Olga Bloch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Bloch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Bloch. The network helps show where Olga Bloch may publish in the future.

Co-authorship network of co-authors of Olga Bloch

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Bloch. A scholar is included among the top collaborators of Olga Bloch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Bloch. Olga Bloch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bloch, Olga, et al.. (2023). Severe and fatal COVID‐19 is characterised by increased circulating glucagon like peptide 1 and procalcitonin modulated by type 2 diabetes. Diabetes/Metabolism Research and Reviews. 39(6). e3635–e3635. 1 indexed citations
2.
Bloch, Olga, et al.. (2021). Coronary atherosclerosis severity is closely associated with decreased GLP-1R positivity among CD16+ pro-inflammatory and patrolling monocyte subsets. SHILAP Revista de lepidopterología. 46. 15–19. 2 indexed citations
4.
Perl, Sivan, et al.. (2018). Sepsis‐induced activation of endogenous GLP‐1 system is enhanced in type 2 diabetes. Diabetes/Metabolism Research and Reviews. 34(4). e2982–e2982. 31 indexed citations
5.
Elbaz‐Greener, Gabby, et al.. (2018). Endogenous glucagon‐like peptide‐1 system response is impaired during ST‐elevation myocardial infarction in type 2 diabetes patients. Diabetes Obesity and Metabolism. 21(1). 194–198. 5 indexed citations
6.
Broide, Efrat, et al.. (2014). Reduced GLP-1R Expression in Gastric Glands of Patients With Type 2 Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism. 99(9). E1691–E1695. 11 indexed citations
7.
Broide, Efrat, et al.. (2013). GLP-1 Receptor Is Expressed in Human Stomach Mucosa. Journal of Histochemistry & Cytochemistry. 61(9). 649–658. 20 indexed citations
8.
Rachmiel, Marianna, et al.. (2011). Young patients with both type 1 diabetes mellitus and asthma have a unique IL-12 and IL-18 secretory pattern. Pediatric Diabetes. 12(7). 596–603. 15 indexed citations
10.
Bloch, Konstantin, et al.. (2010). A strategy for the engineering of insulin producing cells with a broad spectrum of defense properties. Biomaterials. 32(7). 1816–1825. 12 indexed citations
11.
Molad, Yair, et al.. (2009). Increased ERK and JNK activities correlate with disease activity in patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 69(1). 175–180. 31 indexed citations
12.
Broide, Efrat, et al.. (2008). Evidence for Aberrant Regulation of MAP Kinase Signal Transduction Pathway in Peripheral Blood Mononuclear Cells in Patients with Active Celiac Disease. Digestive Diseases and Sciences. 54(6). 1270–1275. 7 indexed citations
13.
Ewart, H. Stephen, Olga Bloch, Jaroslav A. Kralovec, et al.. (2007). Stimulation of Cytokine Production in Human Peripheral Blood Mononuclear Cells by an Aqueous Chlorella Extract. Planta Medica. 73(8). 762–768. 16 indexed citations
14.
Rachmiel, Marianna, Olga Bloch, Naomi Weintrob, et al.. (2006). Clinical Characteristics and Diabetes Associated Autoantibodies in Patients with Both Type 1 Diabetes Mellitus and Asthma. Journal of Pediatric Endocrinology and Metabolism. 19(8). 1001–6. 2 indexed citations
15.
Bloch, Konstantin, et al.. (2006). Improved activity of streptozotocin‐selected insulinoma cells following microencapsulation and transplantation into diabetic mice. Cell Biology International. 30(2). 138–143. 9 indexed citations
16.
Rachmiel, Marianna, Olga Bloch, T. Bistritzer, et al.. (2006). TH1/TH2 cytokine balance in patients with both type 1 diabetes mellitus and asthma. Cytokine. 34(3-4). 170–176. 30 indexed citations
18.
Scapa, Erez, Ohad Cohen, Olga Bloch, et al.. (2004). Enhanced glucose‐dependent glucagon‐like peptide‐1 and insulin secretion in Crohn patients with terminal ileum disease is unrelated to disease activity or ileal resection. Scandinavian Journal of Gastroenterology. 39(7). 650–656. 21 indexed citations
19.
Harel, Avikam, Olga Bloch, Pnina Vardi, & Konstantin Bloch. (2002). Sensitivity of HaCat keratinocytes to diabetogenic toxins. Biochemical Pharmacology. 63(2). 171–178. 12 indexed citations
20.
Bloch, Konstantin, et al.. (1999). Streptozotocin and Alloxan‐based Selection Improves Toxin Resistance of Insulin‐Producing RINm Cells. Journal of Diabetes Research. 1(3). 211–219. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026